Alto Neuroscience
(NYSE) ANRO
Alto Neuroscience Financials at a Glance
Market Cap
$727.72M
Revenue (TTM)
$0.00
Net Income (TTM)
$63.24M
EPS (TTM)
$-2.24
P/E Ratio
-10.15
Dividend
$0.00
Beta (Volatility)
1.66 (High)
Dividend
$0.00
Beta (Volatility)
1.66 (High)
Price
$25.40
Volume
18,522
Open
$22.84
Price
$25.40
Volume
18,522
Open
$22.84
Previous Close
$22.78
Daily Range
$22.84 - $25.80
52-Week Range
$2.02 - $25.80
Dividend
$0.00
Beta (Volatility)
1.66 (High)
Price
$25.40
Volume
18,522
Open
$22.84
Previous Close
$22.78
Daily Range
$22.84 - $25.80
52-Week Range
$2.02 - $25.80
ANRO News
ANRO: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Alto Neuroscience
Industry
Pharmaceuticals
Sector
Health CareEmployees
68
CEO
Amit Etkin, MD, PhD
Website
www.altoneuroscience.comHeadquarters
Mountain View, CA 94022, US
ANRO Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-42%
Return on Capital
-38%
Return on Assets
-34%
Earnings Yield
-9.85%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$727.72M
Shares Outstanding
31.95M
Volume
18.52K
Short Interest
0.00%
Avg. Volume
256.01K
Financials (TTM)
Gross Profit
$661.00K
Operating Income
$66.36M
EBITDA
$65.70M
Operating Cash Flow
$51.77M
Capital Expenditure
$24.00K
Free Cash Flow
$51.79M
Cash & ST Invst.
$176.48M
Total Debt
$4.41M
Alto Neuroscience Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$157.00K
+7.6%
Gross Margin
0.00%
N/A
Market Cap
$727.72M
N/A
Market Cap/Employee
$9.58M
N/A
Employees
76
N/A
Net Income
$16.18M
-6.5%
EBITDA
$16.90M
-15.0%
Quarterly Fundamentals
Net Cash
$152.53M
+0.8%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$22.22M
+38.2%
Short Term Debt
$1.74M
+99.5%
Return on Assets
-34.24%
N/A
Return on Invested Capital
-38.28%
N/A
Free Cash Flow
$11.52M
+14.9%
Operating Cash Flow
$11.52M
+11.6%